Skip to main content
. 2022 Mar 1;15:39. doi: 10.1186/s12920-022-01194-z

Fig. 2.

Fig. 2

Prognostic analysis of a 10-biomarker signature in TCGA cohort and GEO matrix. A, B Kaplan–Meier curves for two different-risk melanoma patient groups in TCGA cohort and GEO matrix, respectively. C, D PCA plots of the melanoma patients in TCGA cohort and GEO matrix, respectively. E, F the ROC curves of 3, 5, and 10 years of survival rates using 10 genes prognostic model in TCGA cohort and GEO matrix, respectively